Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-26 @ 4:44 PM
Study NCT ID:
NCT01590459
Status:
COMPLETED
Last Update Posted:
2015-11-20
First Post:
2012-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate
Sponsor:
Vertex Pharmaceuticals Incorporated